Latest Regulatory News

Almonty Industries has announced a $700 million convertible senior notes offering due 2031, aiming to refinance existing debt and fund corporate initiatives amid rising tungsten demand.

Silver Mines has locked in a $7.56 million capital raise by entering an underwriting agreement with Petra Capital to cover the exercise of nearly 63.2 million unlisted options expiring mid-June.

Findi Limited has transitioned Stephen Benton to Non-Executive Chairman while Nicholas Smedley refocuses on the Indian business and TSI IPO plans. A strategic review aims to sharpen capital allocation and progress the Payments Bank licence.

AuKing Mining expands its footprint at the Tundulu Rare Earths Project in Malawi through a structured earn-in agreement and a fresh airborne survey revealing a larger carbonatite system with multiple new drill targets.

Brazilian Critical Minerals (ASX: BCM) reports robust magnesium sulphate leach results from its 2025 drilling at the Ema project, validating key assumptions for a long-life, low-cost rare earth operation.

Ryman Healthcare nearly doubles operating profitability and generates positive free cash flow for the first time in over a decade, while shifting strategy toward sustainable growth and targeting dividend returns by FY28.

Ardea Resources' Kalgoorlie Nickel Project – Goongarrie Hub has been awarded Lead Agency Status by the Western Australian Government, marking a key regulatory milestone that underscores its strategic importance in the critical minerals sector.

Janus Electric boosts its North American footprint with expanded US orders, significant government subsidies slashing conversion costs, and key infrastructure partnerships advancing.

EBR Systems has secured a significant regulatory milestone as the US Centers for Medicare & Medicaid Services (CMS) initiates a National Coverage Determination (NCD) for its WiSE wireless cardiac pacing system, aiming for approval by early 2027.

TMK Energy reports a steady increase in gas output and launches a 1MW Gas to Power pilot in Mongolia, aiming to boost well performance and secure a production license.

Island Pharmaceuticals has kicked off GMP manufacturing of its antiviral Galidesivir to support late-stage Marburg virus studies under the FDA Animal Rule, marking a key step towards regulatory submission and biodefence readiness.

Macarthur Minerals has approved a joint venture where Gold Valley assigns half its interest in the Lake Giles Ularring Hematite Project to Destec, bringing fresh operational expertise to the venture while Macarthur retains full ownership of its tenements.